(Q40862068)

24 September 2017

Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. (English)

1 reference

24 September 2017

1 reference

Iizuka N

1

1 reference

24 September 2017

Miyamoto K

2

1 reference

24 September 2017

Hazama S

3

1 reference

24 September 2017

Yoshino S

4

1 reference

24 September 2017

Yoshimura K

5

1 reference

24 September 2017

Okita K

6

1 reference

24 September 2017

Fukumoto T

7

1 reference

24 September 2017

Yamamoto S

8

1 reference

24 September 2017

Tangoku A

9

1 reference

24 September 2017

Oka M

10

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

24 September 2017

1 reference

24 September 2017

158

1 reference

24 September 2017

35-41

1 reference

24 September 2017

1

1 reference

The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

1 reference

7 January 2021

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Relative inhibitory activity of berberine-type alkaloids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Inhibition of activator protein 1 activity by berberine in human hepatoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

The influence of interleukin-6 on the growth of human esophageal cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

[Comparative studies on concentration of berberine in plasma after oral administration of coptidis rhizoma extract, its cultured cells extract, and combined use of these extracts and glycyrrhizae radix extract in rats]

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Is there a role for melatonin in the treatment of neoplastic cachexia?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

1 reference

7 January 2021

Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Flowcytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900496-1

7 January 2021

10.1016/S0304-3835(00)00496-1

Identifiers

DOI

1 reference

24 September 2017

1 reference